Draft:NeurGear (ZenBud)
| Submission declined on 28 April 2025 by Sophisticatedevening (talk). This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: In accordance with Wikipedia's Conflict of interest policy, I disclose that I have a conflict of interest regarding the subject of this article. HackNeurotech (talk) 21:35, 28 April 2025 (UTC)
| Industry | Biotechnology, Neurotechnology, Consumer Health Technology |
|---|---|
| Founded | 2022 |
| Founder | Jon Hacker |
| Headquarters | Rochester, New York, U.S. |
Key people | Jonathan Hacker (Founder & CEO) |
| Products | ZenBud (Ultrasound Vagus Nerve Stimulator) |
| Website | zenbud.health |
NeurGear (ZenBud)
[edit]NeurGear is a U.S.-based biotechnology company specializing in non-invasive neuromodulation technologies. The company focuses on developing wearable devices that utilize low-intensity focused ultrasound (LIFU) to stimulate the vagus nerve, aiming to promote relaxation, improve mental health, and reduce symptoms associated with anxiety, depression, PTSD, and related conditions.
History
[edit]NeurGear was founded in 2022 by biomedical engineer Jonathan Hacker. Originating from a multidisciplinary project at the Rochester Institute of Technology (RIT), the company was formed to create accessible neurotechnology solutions for mental health and human performance enhancement. NeurGear has showcased its innovations at events including Maker Faire Rochester, Imagine RIT, the Consumer Electronics Show (CES) 2024, and the Biohacking Day of Consciousness hosted by Dave Asprey.[1]
In 2023, NeurGear introduced its first product, ZenBud, which gained recognition among emerging wearable neurotechnologies at CES 2024.[2]
Products
[edit]ZenBud
[edit]ZenBud is NeurGear's flagship product, a non-invasive wearable device designed to deliver low-intensity focused ultrasound (LIFU) to the auricular branch of the vagus nerve. Unlike traditional electrical stimulation devices, ZenBud employs targeted acoustic energy to stimulate vagal pathways through the skin without requiring implanted hardware.
ZenBud is worn similarly to an earbud and is intended for general wellness purposes, including stress reduction, sleep improvement, cognitive resilience, and emotional regulation. It is not approved for the medical treatment of any specific conditions.
ZenBud is available for direct consumer purchase through NeurGear's website, Caputron,[3] and major online retailers including Walmart.[4]
Clinical Research
[edit]A preliminary clinical study investigating the safety, feasibility, and efficacy of the ZenBud device was conducted and posted as a preprint with JMIR Neurotechnology.[5]
The study enrolled 28 participants with moderate to severe anxiety symptoms (Beck Anxiety Inventory score ≥16). Participants used the device daily for five minutes over four weeks. Reported outcomes included:
- A 14.9-point average reduction in Beck Anxiety Inventory (BAI) scores (from 26.5 to 11.5, p<.001).
- A 10.3-point reduction in Beck Depression Inventory (BDI) scores (p<.001).
- A 20-point reduction in PTSD Checklist for DSM-5 (PCL-5) scores (p<.001).
- 79% of participants achieved remission from moderate or severe anxiety symptoms.
- 77.8% of participants who initially met criteria for provisional PTSD no longer met the threshold after four weeks.
- Only one mild, temporary adverse event was reported.
The study concluded that LIFU targeting the vagus nerve with ZenBud was well tolerated and provided significant preliminary reductions in anxiety, depression, and PTSD symptoms, warranting further investigation.
Technology and Approach
[edit]NeurGear’s ZenBud utilizes low-intensity focused ultrasound (LIFU) targeted at the auricular branch of the vagus nerve. Unlike electrical stimulation devices (such as transcutaneous electrical nerve stimulation, or tVNS), ultrasound stimulation offers potential advantages in precision, comfort, and depth of tissue penetration.[6]
ZenBud is part of a broader trend toward non-invasive vagus nerve stimulation (nVNS) devices aimed at modulating the autonomic nervous system to enhance parasympathetic ("rest and digest") activity and reduce sympathetic ("fight or flight") dominance.
Recognition and Public Engagement
[edit]In addition to CES 2024 and Maker Faire appearances, NeurGear has engaged in public speaking, workshops, and collaborations with mental health and wellness organizations to promote broader adoption of neuromodulation technologies.
NeurGear’s technology and business model have been featured in publications covering biohacking, wellness technology, and consumer neuroscience innovation.[7]
See Also
[edit]- Non-Invasive Vagus Nerve Stimulation Devices
- Vagus nerve stimulation
- Neuromodulation
- Ultrasound therapy
- Biohacking
References
[edit]- ^ "ZenBud Debuts at Biohacking Day of Consciousness". ZenBud Health.
- ^ "CES 2024: Innovative Wearables on Display". Cerebral Overload.
- ^ "ZenBud - Caputron". Caputron.
- ^ "ZenBud - Walmart Listing". Walmart.
- ^ Kohler I, Hacker J, Martin E (2024). "Reduction of Anxiety Related Symptoms Using Low Intensity Ultrasound Neuromodulation on the Auricular Branch of the Vagus Nerve: A Preliminary Study". JMIR Preprints.
- ^ Yap J, Keatch C, Lambert E, Woods W, Stoddart PR, Kameneva T (2020). "Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical Practice". Frontiers in Neuroscience. 14: 284. doi:10.3389/fnins.2020.00284. PMC 7199464. PMID 32410932.
{{cite journal}}: Vancouver style error: initials in name 1 (help) - ^ "Top Emerging Neurotech Companies to Watch". Tech Reviewed.
- in-depth (not just brief mentions about the subject or routine announcements)
- reliable
- secondary
- strictly independent of the subject
Make sure you add references that meet all four of these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.